X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6257) 6257
Book Review (939) 939
Publication (854) 854
Conference Proceeding (127) 127
Book Chapter (49) 49
Dissertation (26) 26
Book / eBook (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4409) 4409
kras (3984) 3984
humans (3973) 3973
oncology (2984) 2984
mutation (2779) 2779
female (2180) 2180
male (1957) 1957
cancer (1914) 1914
colorectal cancer (1728) 1728
middle aged (1713) 1713
aged (1594) 1594
ras proteins - genetics (1235) 1235
adult (1234) 1234
genetic aspects (1125) 1125
colorectal neoplasms - genetics (1109) 1109
proto-oncogene proteins - genetics (1080) 1080
proto-oncogene proteins p21 (1060) 1060
chemotherapy (1057) 1057
tumors (1012) 1012
braf (1004) 1004
egfr (991) 991
cetuximab (981) 981
prognosis (972) 972
kras mutations (949) 949
aged, 80 and over (893) 893
pathology (873) 873
colorectal neoplasms - pathology (861) 861
metastasis (836) 836
proto-oncogene proteins p21 - genetics (834) 834
adenocarcinoma (810) 810
lung neoplasms - genetics (799) 799
animals (789) 789
analysis (755) 755
proto-oncogene proteins b-raf - genetics (738) 738
research (684) 684
gene mutations (680) 680
survival (679) 679
expression (678) 678
lung cancer (675) 675
mutations (669) 669
colorectal neoplasms - drug therapy (640) 640
cell biology (639) 639
care and treatment (629) 629
kras mutation (627) 627
growth-factor receptor (590) 590
neoplasms (590) 590
digestive system diseases (589) 589
adenocarcinoma - genetics (577) 577
cell line, tumor (558) 558
article (551) 551
biomarkers, tumor - genetics (546) 546
dna mutational analysis (537) 537
therapy (536) 536
carcinoma (530) 530
k-ras (527) 527
mice (524) 524
lung neoplasms - pathology (518) 518
microsatellite instability (502) 502
pancreatic cancer (492) 492
1st-line treatment (486) 486
receptor, epidermal growth factor - genetics (478) 478
carcinoma, non-small-cell lung - genetics (462) 462
panitumumab (440) 440
mutation - genetics (434) 434
neoplasm staging (434) 434
health aspects (433) 433
antineoplastic agents - therapeutic use (432) 432
immunohistochemistry (427) 427
gefitinib (424) 424
colon-cancer (422) 422
colorectal-cancer (419) 419
genes (418) 418
respiratory system (402) 402
signal transduction (400) 400
retrospective studies (393) 393
treatment outcome (393) 393
epidermal growth factor (392) 392
biochemistry & molecular biology (381) 381
adenocarcinoma - pathology (374) 374
kinases (374) 374
development and progression (368) 368
polymerase chain reaction (368) 368
cell lung-cancer (367) 367
patients (367) 367
proteins (365) 365
deoxyribonucleic acid--dna (363) 363
gene (358) 358
surgery (355) 355
antineoplastic combined chemotherapy protocols - therapeutic use (354) 354
disease-free survival (354) 354
medicine & public health (351) 351
receptor, epidermal growth factor - antagonists & inhibitors (349) 349
gene expression (346) 346
biomarkers (345) 345
genes, ras (340) 340
ras (340) 340
k-ras mutations (337) 337
cancer therapies (334) 334
neoplasm metastasis (333) 333
activation (332) 332
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6248) 6248
French (72) 72
German (26) 26
Chinese (20) 20
Spanish (19) 19
Russian (13) 13
Japanese (7) 7
Korean (7) 7
Polish (5) 5
Czech (3) 3
Persian (2) 2
Hungarian (1) 1
Portuguese (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Discovery, ISSN 2159-8274, 07/2018, Volume 8, Issue 7, pp. 822 - 835
KRAS is the most common oncogenic driver in lung adenocarcinoma (LUAC). We previously reported that STK11/LKB1 (KL) or TP53 (KP) comutations define distinct... 
CTLA-4 BLOCKADE | CANCER-PATIENTS | MELANOMA | ONCOLOGY | COOCCURRING GENOMIC ALTERATIONS | OPEN-LABEL | RANDOMIZED CONTROLLED-TRIAL | NIVOLUMAB | LKB1 LOSS | DOCETAXEL | TUMOR MICROENVIRONMENT | non-small cell lung cancer | PD-1 blockade | STK11 | KRAS | LKB1 | lung adenocarcinoma
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2013, Volume 369, Issue 11, pp. 1023 - 1034
Patients who have colorectal cancer with RAS mutations in exon 2 are unlikely to respond to EGFR blockers. A retrospective analysis of tumors containing other,... 
SURVIVAL | 1ST-LINE TREATMENT | LUNG-CANCER | MEDICINE, GENERAL & INTERNAL | LEUCOVORIN | RANDOMIZED PHASE-III | CETUXIMAB PLUS IRINOTECAN | BRAF | KRAS CODON 12 | FLUOROURACIL | CHEMOTHERAPY | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Membrane Proteins - genetics | Colorectal Neoplasms - genetics | Humans | Antibodies, Monoclonal - therapeutic use | Proto-Oncogene Proteins - genetics | Disease-Free Survival | Fluorouracil - therapeutic use | Neoplasm Metastasis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | GTP Phosphohydrolases - genetics | Proto-Oncogene Proteins B-raf - genetics | Colorectal Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Leucovorin - therapeutic use | Mutation | Colorectal Neoplasms - pathology | Genes, ras | Organoplatinum Compounds - therapeutic use | Care and treatment | Dosage and administration | Research | Gene mutations | Panitumumab | Colorectal cancer | Hypothesis testing | Medical research | Statistical analysis | Epidermal growth factor receptors | Colorectal carcinoma | Metastasis | Cancer therapies | Survival | Patients | Metastases | Studies | Hypotheses | Chemotherapy | Epidermal growth factor | Oxaliplatin | Testing laboratories | Medical prognosis | Biomarkers | Deoxyribonucleic acid--DNA | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 06/2011, Volume 6, Issue 6, pp. 1006 - 1015
Journal Article
The Journal of Pathology, ISSN 0022-3417, 12/2013, Volume 231, Issue 4, pp. 449 - 456
BRAF and KRAS mutations in ovarian serous borderline tumours ( OSBTs ) and ovarian low‐grade serous carcinomas ( LGSCs ) have been previously described.... 
mutation | deep sequencing | ovarian low‐grade serous carcinoma | KRAS | BRAF | serous borderline tumour | COLD‐PCR | COLD-PCR | ovarian low-grade serous carcinoma | SURVIVAL | NEOPLASMS | IMPLANTS | PATHOLOGY | PATHOGENESIS | CANCER GENOMICS | ONCOLOGY | RAS MUTATIONS | PROTEIN MUTATIONS | EXPRESSION | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Prognosis | Humans | Middle Aged | Ovarian Neoplasms - pathology | Cystadenocarcinoma, Serous - genetics | Cystadenocarcinoma, Serous - pathology | DNA Mutational Analysis - methods | Neoplasm Recurrence, Local - pathology | Ovarian Neoplasms - genetics | Young Adult | Neoplasm Grading | Adult | Female | Cell Death - drug effects | Tumor Cells, Cultured | High-Throughput Nucleotide Sequencing - methods | MAP Kinase Kinase Kinases - antagonists & inhibitors | Neoplasm Proteins - genetics | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Proto-Oncogene Proteins B-raf - genetics | Benzimidazoles - pharmacology | Neoplasm Recurrence, Local - genetics | Aged | Protein Kinase Inhibitors - pharmacology | DNA, Neoplasm - genetics | Mutation | Cystadenoma, Serous - genetics | Cystadenoma, Serous - pathology | Proteins | Relapse | Carcinoma | Gene mutations | Genomics | Analysis | Denaturation | Cancer | Diseases | Index Medicus | KRAS mutation | Ovarian low-grade serous carcinoma | Serous borderline tumor | Deep sequencing | KRAS G12V | BRAF mutation | Full COLD-PCR
Journal Article
Cancer, ISSN 0008-543X, 11/2013, Volume 119, Issue 21, pp. 3776 - 3783
Journal Article
Nature, ISSN 0028-0836, 06/2012, Volume 486, Issue 7404, pp. 532 - 536
Journal Article
Lung Cancer, ISSN 0169-5002, 2009, Volume 69, Issue 3, pp. 279 - 283
Journal Article
Journal Article
Journal of Medical Genetics, ISSN 0022-2593, 12/2007, Volume 44, Issue 12, pp. 763 - 771
Journal Article